Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA approval of novel Claritin formulation sought

June 21, 1996

Intranasal NPY: Potential allergic rhinitis agent

June 21, 1996

PDE IV inhibitor selected for further study

June 14, 1996

Sankyo reveals PAF antagonists

June 14, 1996

LTB4 antagonists from Pfizer

June 14, 1996

Schering-Plough seeks Nasonex approval

June 14, 1996

Phase III trials on Kyowa Hakko's olopatidine HCl complete

June 7, 1996

SJC13: LPS-stimulated adhesion inhibitor

June 7, 1996

Searle discloses LTA4 hydrolase inhibitors

June 7, 1996

Sanofi Winthrop research reveals elastase inhibitors

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...